EPA Provides Expedited Pathway for Companies to Claim “Long-Lasting” Efficacy for Antiviral Products
By EsqSocial Corporation 26/10/20
On October 14, 2020, the U.S. Environmental Protection Agency (EPA) released a much-anticipated draft guidance that is intended to help companies demonstrate to EPA that their products have “long-lasting” or “residual” effectiveness on surfaces against viruses like SARS-CoV-2, the coronavirus that causes COVID-19. EPA has not before now provided guidance on how stakeholders can demonstrate to EPA’s satisfaction that their product remains efficacious for periods of time given the broad diversity...
By: Bergeson & Campbell, P.C.